These super high-flying US stocks have soared 222%, 122%, and 150%, respectively, in 2025. Let's take a look why.

It may be early, but some blazing investments have already delivered wealth-altering gains in this young year.

Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

There are many reasons, but the most important is reduced reimbursement for prescription drugs. Most community pharmacies operate under a business model centered on dispensing medications that relies ...